About / Media Center
Trinity News
Filter by Type:
The Business Case for RWE
Trinity experts were featured in Pharmaceutical Commerce Magazine Trinity’s Nandini Hadker, Nabha Naga Subramanya and Adrienne Lovink were featured in Pharmaceutical Commerce Magazine’s article “The Business Case for RWE.” Read the article to learn more about how drugmakers can better harness real-world evidence to drive their clinical and...
Does private equity have a real-world data strategy?
As the pharma services sector continues to consolidate, RWD is emerging as a critical piece of the commercialization offering. Trinity Life Sciences’ President & CEO, Leslie Orne, was featured in an article in MM+M to discuss this topic.
Changing the Pharmaceutical Commercialization Landscape
Three emerging trends have the power to reshape multiple aspects of the commercialization process. These include: 1) the value of taking a phased approach to product launches, 2) the rapidly expanding potential of artificial intelligence (AI) based technologies to optimize multiple...
Leslie Orne – President & CEO – Trinity Life Sciences
Hear from Leslie Orne, President and CEO of Trinity Life Sciences, as she shares her thoughts on strategic innovation for pharmaceutical commercialization in an interview on the Progress, Potential, and Possibilities Podcast.
Strategies for Success in an Evolving Commercialization Landscape
Trinity Life Sciences’ President and CEO, Leslie Orne, authored an article in Pharmaceutical Executive. To learn about strategies for success in an evolving commercial landscape, read the article.
Recent Hires, Layoffs & an Interview with Leslie Orne, CEO of Trinity Life Sciences
Hear from Leslie Orne, President and CEO of Trinity Life Sciences, as she shares her thoughts on the current biotech renaissance and AI innovation in the life sciences space in an interview on the MedCity News podcast Healthcare Moves.
Disruptive Factors Shape RA Landscape
Trinity experts were featured in Pharmaceutical Commerce Magazine In this article written by Suzanne Shelley entitled “Disruptive Factors Shape RA Landscape” for Pharmaceutical Commerce Magazine, Akshay Mehta, Principal, Strategic Advisory, Trinity Life Sciences, and Mary Lynn Kelley, Vice President, Patient Support Services, TGaS...
Payer Perceptions of Nonclinical Value Drivers
Trinity experts Maximilian Hunt, BS, Ismail Ismailoglu, PhD, Grace Mock, BA, and Helen Amata, MPH have been featured in ISPOR’s Value & Outcomes Spotlight
Pharma can ‘no longer rely on traditional sales and marketing’ to launch new drugs: report
Trinity’s recent white paper, titled Empowering the Next-Generation Launch Model, was featured in a recent article by Fierce Pharma.
Demand for Real-World Evidence of Medications is Growing
Trinity’s recent white paper, titled Dawn of a New Era: Evolving Needs, Solutions and Technology in U.S. HEOR, was featured in a recent article by Formulary Watch.
Enough with data collection, FDA needs diversity policies to boost representation in clinical trials: report
Trinity's recent whitepaper, titled Diversity in Clinical Trials Participation: A Life Sciences Perspective, was featured in a recent article by Fierce Biotech.
Google’s Cookie Ban Delay Prompts Sighs of Relief, but Pharma Advertisers Shouldn’t Get Complacent
Third-party tracking cookies aren’t as important to pharma as they are to consumer marketers. Automakers, for instance, can follow online car shoppers, putting targeted digital ads in buyers’ paths as they move across the internet hoping for a sale. However, privacy policies...